.Attribute Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for inclusion of people along with MASLD as well as size of liver end results in cardio-- kidney-- metabolic tests, when data advise mechanistically conceivable benefits and medical protection-- and also describes considerations for trial concept and also governing approval.